Amdocs Net Income Common Stock Trend from 2010 to 2022

DOX
 Stock
  

USD 88.95  1.36  1.55%   

Amdocs Net Income Common Stock yearly trend continues to be fairly stable with very little volatility. Net Income Common Stock will likely drop to about 673.8 M in 2022. During the period from 2010 to 2022, Amdocs Net Income Common Stock regression line of anual values had slope of 29,155,704 and arithmetic mean of  488,488,797. Amdocs Interest Expense is fairly stable at the moment as compared to the past year. Amdocs reported Interest Expense of 12.42 Million in 2021. Weighted Average Shares is likely to rise to about 126.6 M in 2022, whereas Direct Expenses is likely to drop slightly above 2.3 B in 2022.
  
Check Amdocs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amdocs main balance sheet or income statement drivers, such as Direct Expenses of 2.3 B, Consolidated Income of 673.8 M or Cost of Revenue of 3.1 B, as well as many exotic indicators such as Interest Coverage of 42.95, Long Term Debt to Equity of 0.16 or Calculated Tax Rate of 13.17. Amdocs financial statements analysis is a perfect complement when working with Amdocs Valuation or Volatility modules. It can also supplement Amdocs' financial leverage analysis and stock options assessment as well as various Amdocs Technical models . Continue to the analysis of Amdocs Correlation against competitors.

Amdocs Quarterly Net Income Common Stock

128.47 Million

Amdocs Net Income Common Stock Breakdown

Showing smoothed Net Income Common Stock of Amdocs Limited with missing and latest data points interpolated. The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.Amdocs' Net Income Common Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amdocs' overall financial position and show how it may be relating to other accounts over time.
Net Income Common Stock10 Years Trend
Increasing
Slightly volatile
   Net Income Common Stock   
Share
       Timeline  

Amdocs Net Income Common Stock Regression Statistics

Arithmetic Mean 488,488,797
Geometric Mean 472,509,549
Coefficient Of Variation 28.63
Mean Deviation 107,329,258
Median 436,826,000
Standard Deviation 139,875,383
Range 444,965,100
R-Value 0.81
R-Squared 0.66
Significance 0.00075234
Slope 29,155,704

Amdocs Net Income Common Stock History

2012412.4 M
2013422.1 M
2014446.2 M
2015409.3 M
2016436.8 M
2017354.4 M
2018479.4 M
2019497.8 M
2020688.4 M
2021791.6 M
2022673.8 M

Other Fundumenentals of Amdocs Limited

Amdocs Net Income Common Stock component correlations

About Amdocs Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Amdocs income statement, its balance sheet, and the statement of cash flows. Amdocs investors use historical funamental indicators, such as Amdocs's Net Income Common Stock, to determine how well the company is positioned to perform in the future. Although Amdocs investors may use each financial statement separately, they are all related. The changes in Amdocs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amdocs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amdocs Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amdocs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Net Income Common Stock791.6 M673.8 M
Net Income Per Employee22.8 K19.8 K
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 31000 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amdocs without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module
Continue to the analysis of Amdocs Correlation against competitors. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.089
Market Capitalization
10.9 B
Quarterly Revenue Growth YOY
0.088
Return On Assets
0.0605
Return On Equity
0.15
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.